ALGS vs PSA · rev $3.6M vs rev $4.82B
Aligos Therapeutics Inc (ALGS) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
PSA (PSA) common stock.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
ALGS currently screens at market cap $44.1M. PSA currently screens at market cap $0.
Not investment advice. Open the ALGS and PSA stock pages for the full models.
Not investment advice.